Bank of America Securities Keeps Their Hold Rating on Arcus Biosciences (RCUS)
at www.tipranks.com (Thu, 15-Jan 6:28 AM)
Arcus Halts STAR-221 Study, Sharpens Focus on Casdatifan and Next-Gen Inflammation Portfolio
Market Chameleon (Fri, 12-Dec 8:57 AM)
Arcus Biosciences Prices $250 Million Stock Offering—Key Takeaways for Investors
Market Chameleon (Fri, 31-Oct 9:11 AM)
